National Resilience To Invest $225M In Cincinnati Site

National Resilience, a technology-focused biomanufacturing company, will expand clinical and commercial drug product manufacturing.

A technology-focused biomanufacturing company will expand its clinical and commercial drug product manufacturing in two states.

National Resilience expects to invest at least $225 million in its Cincinnati site to increase production capacity and also will expand its drug-product capabilities at its RTP site in North Carolina. The company’s growth should give it the ability to provide more than 200 million units to partners “across its manufacturing network by 2025.”

(Photo: Adobe Stock/ leowolfert)

“Strengthening our drug product manufacturing capacity across the Resilience network highlights our commitment to providing robust and scalable outsourcing options for our partners,” said Rahul Singhvi, Sc.D., Chief Executive Officer of National Resilience. “As a highly experienced team already supporting a leading pharmaceutical company with their GLP-1 products, this expansion further supports Resilience’s mission to ensure adequate biomanufacturing capacity by addressing and overcoming historic manufacturing challenges throughout the industry.”

How Investing In Sites And Infrastructure In Ohio Will Help Your Business Thrive

With infrastructure assets spanning roads, rails, runways, and waterways, Ohio offers your business the flexibility and connectivity it needs to thrive. Read more…

The FDA-licensed site in Ohio currently has “three high speed fill lines for vials, cartridges, and pre-filled syringes (PFS), with a fourth PFS fill line ready by 2025,” the company said. The facility also is expected to have six device-assembly and packaging suites by 2025.

In RTP site in North Carolina, growth plans include a new state-of-the-art Bausch & Strobel Isolator filler, the company said.

National Resilience was founded in 2020 and aims to advance the science of biopharmaceutical manufacturing and development.

Check out all the latest news related to Ohio economic development, corporate relocation, corporate expansion and site selection.

Biotech, Daily News, Economic Development, Featured, Industries, North Carolina, Ohio, USA - Great Lakes, USA - Southeast

Bausch & Strobel, biopharma, biopharmaceutical manufacturing, National Resilience, north carolina, ohio, Single Location

Sponsored Content
Featured Location
Featured Video

Webinars, Podcasts & Videos

Camp Hall – A Next Generation Commerce Park in South Carolina

Camp Hall is a first-of-its-kind, master-planned industrial work space located in Charleston, S.C. As a convergence of people, place and programming, Camp Hall delivers thoughtful infrastructure and logistical features that empower people — and business — to thrive.

Hear from leaders at the Destination Medical Center and Mayo Clinic Business Development in Rochester about why they feel Minnesota is filled with opportunities for founders and why investors should consider the power of startups in Minnesota.

Business Benefits In Minnesota, a Mayo Clinic Business Development and Destination Medical Center Perspective

Hear from leaders at the Destination Medical Center and Mayo Clinic Business Development in Rochester about why they feel Minnesota is filled with opportunities for founders and why investors should consider the power of startups in Minnesota.

Agricultural Heritage Meets Strong Manufacturing Base With a rich history in agriculture, the region is now made up of a strong manufacturing base, including everything from snack foods and Gatorade, to leading human resources software and revolutionary plug-less power systems for electric vehicles. Mount Rogers Regional Partnership's strategic East Coast location is the driving force.

Virginia’s i81-i77 Crossroads | Talent Retention & Manufacturing

Learn about manufacturing jobs and facilities in the Mount Rogers region of southwest Virginia. There is ample opportunity for education and jobs in a region rich with culture and heritage.

Share to...